Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Goodman

Showing results (111-120 of 347) with videos related to

Pageof 35
Sort By:
Regulatory Toxicology and Pharmacology : RTP|May 18, 2005
Uses of benchmark dose methodology in quantitative risk assessmentThomas B Starr, Jay I Goodman, David G Hoel
Progress in Clinical and Biological Research|January 1, 1990
Clinical and biochemical aspects of glutaric acidemia type IIS I Goodman, J P Loehr, F E Frerman
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 15, 1999
Stimulating research to improve the scientific basis of risk assessmentR B Conolly, B D Beck, J I Goodman
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 2, 2009
The constitutive active/androstane receptor facilitates unique phenobarbital-induced expression changes of genes involved in key pathways in precancerous liver and liver tumorsJennifer M Phillips, Lyle D Burgoon, Jay I Goodman
Molecular Genetics and Metabolism|September 2, 2003
Pathogenic mutations in the carboxyl-terminal domain of glutaryl-CoA dehydrogenase: effects on catalytic activity and the stability of the tetramerJonna B Westover, Stephen I Goodman, Frank E Frerman
Journal of Clinical Pharmacology|July 1, 1976
Ripazepam (CI-683): double-blind comparison with placebo in anxious patientsJ J Schneyer, L I Goodman, L A Borgen
Pediatric Research|March 1, 1990
Glutaric acidemia type II: heterogeneity of clinical and biochemical phenotypesJ P Loehr, S I Goodman, F E Frerman
Critical Reviews in Toxicology|October 23, 2008
Risk assessment of toxaphene and its breakdown products: time for a change?James C Lamb, Barbara H Neal, Jay I Goodman
Chemico-Biological Interactions|February 11, 1976
Studies on the mechanism of inhibition of 2-acetylaminofluorene toxicity by butylated hydroxytolueneJ I Goodman, J E Trosko, J D Yager
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 16, 2006
Phenobarbital induces progressive patterns of GC-rich and gene-specific altered DNA methylation in the liver of tumor-prone B6C3F1 miceAmmie N Bachman, Jennifer M Phillips, Jay I Goodman
Pageof 35

Showing results (111-120 of 347) with videos related to

Sort By:
Pageof 35
Regulatory Toxicology and Pharmacology : RTP|May 18, 2005
Uses of benchmark dose methodology in quantitative risk assessmentThomas B Starr, Jay I Goodman, David G Hoel
Progress in Clinical and Biological Research|January 1, 1990
Clinical and biochemical aspects of glutaric acidemia type IIS I Goodman, J P Loehr, F E Frerman
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 15, 1999
Stimulating research to improve the scientific basis of risk assessmentR B Conolly, B D Beck, J I Goodman
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 2, 2009
The constitutive active/androstane receptor facilitates unique phenobarbital-induced expression changes of genes involved in key pathways in precancerous liver and liver tumorsJennifer M Phillips, Lyle D Burgoon, Jay I Goodman
Molecular Genetics and Metabolism|September 2, 2003
Pathogenic mutations in the carboxyl-terminal domain of glutaryl-CoA dehydrogenase: effects on catalytic activity and the stability of the tetramerJonna B Westover, Stephen I Goodman, Frank E Frerman
Journal of Clinical Pharmacology|July 1, 1976
Ripazepam (CI-683): double-blind comparison with placebo in anxious patientsJ J Schneyer, L I Goodman, L A Borgen
Pediatric Research|March 1, 1990
Glutaric acidemia type II: heterogeneity of clinical and biochemical phenotypesJ P Loehr, S I Goodman, F E Frerman
Critical Reviews in Toxicology|October 23, 2008
Risk assessment of toxaphene and its breakdown products: time for a change?James C Lamb, Barbara H Neal, Jay I Goodman
Chemico-Biological Interactions|February 11, 1976
Studies on the mechanism of inhibition of 2-acetylaminofluorene toxicity by butylated hydroxytolueneJ I Goodman, J E Trosko, J D Yager
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 16, 2006
Phenobarbital induces progressive patterns of GC-rich and gene-specific altered DNA methylation in the liver of tumor-prone B6C3F1 miceAmmie N Bachman, Jennifer M Phillips, Jay I Goodman
Pageof 35